National Registry of Rare Kidney Diseases
Launched by UK KIDNEY ASSOCIATION · Sep 26, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The National Registry of Rare Kidney Diseases is a research project aimed at gathering information from patients who have specific rare kidney diseases. By collecting this data, the researchers hope to create helpful guidelines for diagnosing and treating these conditions, check how well current treatments are working, and support the development of new therapies. If you or a loved one has one of these rare kidney diseases, you may be invited to participate in clinical trials and other studies, which could provide valuable information about your health and treatment options.
This study is open to both children and adults with rare kidney diseases, and the specific eligibility requirements can vary depending on the condition. Participants can expect to share their experiences and health information, which will be used to improve care for others in the future. Additionally, through a partnership with Patients Know Best, patients have the opportunity to report their own quality of life and health outcomes, making it easier for everyone to understand the impact of these diseases. If you think you might qualify, more details can be found at the provided link.
Gender
ALL
Eligibility criteria
- • Kidney Rare Disease
- • Paeds and adults
- • Eligibility differs for each rare disease group
- • See: https://ukkidney.org/rare-renal/recruitment
About Uk Kidney Association
The UK Kidney Association is a leading organization dedicated to advancing research and improving patient care in the field of nephrology. As a clinical trial sponsor, the Association focuses on fostering innovative studies that aim to enhance understanding and treatment of kidney diseases. By collaborating with healthcare professionals, researchers, and patient advocacy groups, the UK Kidney Association strives to facilitate high-quality clinical research that translates into effective therapies and improved health outcomes for individuals affected by kidney disorders. With a commitment to excellence and patient-centered care, the Association plays a pivotal role in shaping the future of kidney health in the UK and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bristol, South West, United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported